Cargando…

5-Aminolevulinic Acid Photodynamic Therapy Combined with Intralesional Triamcinolone and 5-Fluorouracil to Treat Acne Hypertrophic Scar

BACKGROUND: Acne is a chronic inflammatory disease of the pilosebaceous unit. Improper treatment of acne can lead to skin lesions in some people. Acne hypertrophic scar is relatively rare, but it significantly affects the appearance and beauty, and usually has a great psychological and social impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Jingjing, Du, Lingyun, Cao, Zhiqiang, Li, Mingming, Zhang, Chunhong, Zhang, Chunmin, Meng, Liya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618392/
https://www.ncbi.nlm.nih.gov/pubmed/37920822
http://dx.doi.org/10.2147/CCID.S427427
_version_ 1785129765885181952
author Wei, Jingjing
Du, Lingyun
Cao, Zhiqiang
Li, Mingming
Zhang, Chunhong
Zhang, Chunmin
Meng, Liya
author_facet Wei, Jingjing
Du, Lingyun
Cao, Zhiqiang
Li, Mingming
Zhang, Chunhong
Zhang, Chunmin
Meng, Liya
author_sort Wei, Jingjing
collection PubMed
description BACKGROUND: Acne is a chronic inflammatory disease of the pilosebaceous unit. Improper treatment of acne can lead to skin lesions in some people. Acne hypertrophic scar is relatively rare, but it significantly affects the appearance and beauty, and usually has a great psychological and social impact on patients. OBJECTIVE: To evaluate the clinical efficacy and safety of 5-aminolevulinic acid photodynamic therapy (ALA-PDT) combined with 5-fluorouracil (5-FU) injection and triamcinolone acetonide (TAC) solution in the treatment of acne hypertrophic scars. METHODS: This article included 13 outpatients with acne accompanied by acne hypertrophic scar who were treated from September 2018 to September 2022. All patients received ALA-PDT combined with intralesional injection of 5-FU and TAC. At first, patients received ALA-PDT once every two weeks. After the third ALA-PDT, 5-FU and TAC were mixed in a ratio of 3:7, and then immediately injected in the local scars. The effect was observed after 1 month. If the effect is not obvious, a further injection of 5-FU and TAC to the lesion is necessary. The patients were followed up for 6 months. The Vancouver Scars Scale (VSS) was used to evaluate the efficacy before and after treatment and photos of patients were collected. RESULTS: After ALA-PDT combined with intralesional 5-FU and TAC, all patients achieved good clinical efficacy. 23.08% of patients received one local injection and 76.92% received two local injections. After treatment, the scar lesions were reduced and flattened, and the scars became soft. The total score of VSS after treatment was significantly lower than before, and the difference was statistically significant (P<0.05). The main adverse reactions were pain, erythema, and pigmentation, which can subside within 3 weeks. There was no recurrence after 6 months of follow-up. CONCLUSION: ALA-PDT combined with intralesional injection of 5-FU and TAC significantly affects acne hypertrophic scars, which is worthy of further in-depth and large-scale research.
format Online
Article
Text
id pubmed-10618392
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-106183922023-11-02 5-Aminolevulinic Acid Photodynamic Therapy Combined with Intralesional Triamcinolone and 5-Fluorouracil to Treat Acne Hypertrophic Scar Wei, Jingjing Du, Lingyun Cao, Zhiqiang Li, Mingming Zhang, Chunhong Zhang, Chunmin Meng, Liya Clin Cosmet Investig Dermatol Case Series BACKGROUND: Acne is a chronic inflammatory disease of the pilosebaceous unit. Improper treatment of acne can lead to skin lesions in some people. Acne hypertrophic scar is relatively rare, but it significantly affects the appearance and beauty, and usually has a great psychological and social impact on patients. OBJECTIVE: To evaluate the clinical efficacy and safety of 5-aminolevulinic acid photodynamic therapy (ALA-PDT) combined with 5-fluorouracil (5-FU) injection and triamcinolone acetonide (TAC) solution in the treatment of acne hypertrophic scars. METHODS: This article included 13 outpatients with acne accompanied by acne hypertrophic scar who were treated from September 2018 to September 2022. All patients received ALA-PDT combined with intralesional injection of 5-FU and TAC. At first, patients received ALA-PDT once every two weeks. After the third ALA-PDT, 5-FU and TAC were mixed in a ratio of 3:7, and then immediately injected in the local scars. The effect was observed after 1 month. If the effect is not obvious, a further injection of 5-FU and TAC to the lesion is necessary. The patients were followed up for 6 months. The Vancouver Scars Scale (VSS) was used to evaluate the efficacy before and after treatment and photos of patients were collected. RESULTS: After ALA-PDT combined with intralesional 5-FU and TAC, all patients achieved good clinical efficacy. 23.08% of patients received one local injection and 76.92% received two local injections. After treatment, the scar lesions were reduced and flattened, and the scars became soft. The total score of VSS after treatment was significantly lower than before, and the difference was statistically significant (P<0.05). The main adverse reactions were pain, erythema, and pigmentation, which can subside within 3 weeks. There was no recurrence after 6 months of follow-up. CONCLUSION: ALA-PDT combined with intralesional injection of 5-FU and TAC significantly affects acne hypertrophic scars, which is worthy of further in-depth and large-scale research. Dove 2023-10-27 /pmc/articles/PMC10618392/ /pubmed/37920822 http://dx.doi.org/10.2147/CCID.S427427 Text en © 2023 Wei et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Case Series
Wei, Jingjing
Du, Lingyun
Cao, Zhiqiang
Li, Mingming
Zhang, Chunhong
Zhang, Chunmin
Meng, Liya
5-Aminolevulinic Acid Photodynamic Therapy Combined with Intralesional Triamcinolone and 5-Fluorouracil to Treat Acne Hypertrophic Scar
title 5-Aminolevulinic Acid Photodynamic Therapy Combined with Intralesional Triamcinolone and 5-Fluorouracil to Treat Acne Hypertrophic Scar
title_full 5-Aminolevulinic Acid Photodynamic Therapy Combined with Intralesional Triamcinolone and 5-Fluorouracil to Treat Acne Hypertrophic Scar
title_fullStr 5-Aminolevulinic Acid Photodynamic Therapy Combined with Intralesional Triamcinolone and 5-Fluorouracil to Treat Acne Hypertrophic Scar
title_full_unstemmed 5-Aminolevulinic Acid Photodynamic Therapy Combined with Intralesional Triamcinolone and 5-Fluorouracil to Treat Acne Hypertrophic Scar
title_short 5-Aminolevulinic Acid Photodynamic Therapy Combined with Intralesional Triamcinolone and 5-Fluorouracil to Treat Acne Hypertrophic Scar
title_sort 5-aminolevulinic acid photodynamic therapy combined with intralesional triamcinolone and 5-fluorouracil to treat acne hypertrophic scar
topic Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618392/
https://www.ncbi.nlm.nih.gov/pubmed/37920822
http://dx.doi.org/10.2147/CCID.S427427
work_keys_str_mv AT weijingjing 5aminolevulinicacidphotodynamictherapycombinedwithintralesionaltriamcinoloneand5fluorouraciltotreatacnehypertrophicscar
AT dulingyun 5aminolevulinicacidphotodynamictherapycombinedwithintralesionaltriamcinoloneand5fluorouraciltotreatacnehypertrophicscar
AT caozhiqiang 5aminolevulinicacidphotodynamictherapycombinedwithintralesionaltriamcinoloneand5fluorouraciltotreatacnehypertrophicscar
AT limingming 5aminolevulinicacidphotodynamictherapycombinedwithintralesionaltriamcinoloneand5fluorouraciltotreatacnehypertrophicscar
AT zhangchunhong 5aminolevulinicacidphotodynamictherapycombinedwithintralesionaltriamcinoloneand5fluorouraciltotreatacnehypertrophicscar
AT zhangchunmin 5aminolevulinicacidphotodynamictherapycombinedwithintralesionaltriamcinoloneand5fluorouraciltotreatacnehypertrophicscar
AT mengliya 5aminolevulinicacidphotodynamictherapycombinedwithintralesionaltriamcinoloneand5fluorouraciltotreatacnehypertrophicscar